Are you Dr. Chabria?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 38 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
64 Robbins St
Sixth Floor
Waterbury, CT 06708Phone+1 203-573-6263Fax+1 203-573-6030
Summary
- Dr. Shiven Chabria, MD is an infectious disease specialist in Waterbury, Connecticut. He is currently licensed to practice medicine in Connecticut. He is affiliated with Waterbury Hospital and Yale-New Haven Hospital.
Education & Training
Yale-New Haven Medical CenterFellowship, Infectious Disease, 2012 - 2015
Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 2001 - 2004
N.D.M.V.P. Samaj Medical CollegeClass of 1997
Certifications & Licensure
CT State Medical License 2004 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 12 citationsLong-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1.Peter Ackerman, Melanie Thompson, Jean-Michel Molina, Judith A. Aberg, Isabel Cassetti
AIDS. 2021-06-01 - 52 citationsSafety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE studyMax Lataillade, Jacob Lalezari, Michael J. Kozal, Judith A. Aberg, Gilles Pialoux
The Lancet. HIV. 2020-11-01 - 11 citationsWeek 96 Genotypic and Phenotypic Results of the Fostemsavir Phase 3 BRIGHTE Study in Heavily Treatment-Experienced Adults Living with Multidrug-Resistant HIV-1.Margaret Gartland, Pedro Cahn, Edwin DeJesus, Ricardo Sobhie Diaz, Robert Grossberg
Antimicrobial Agents and Chemotherapy. 2022-06-21
